RT Journal Article
T1 Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update.
T2 Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento no farmacológico.
A1 Cosío, Borja G
A1 Hernández, Carme
A1 Chiner, Eusebi
A1 Gimeno-Santos, Elena
A1 Pleguezuelos, Eulogio
A1 Seijas, Nuria
A1 Rigau, David
A1 López-Campos, José Luis
A1 Soler-Cataluña, Juan José
A1 Calle, Myriam
A1 Miravitlles, Marc
A1 Casanova, Ciro
A1 en nombre del equipo de trabajo de GesEPOC 2021, 
K1 Actividad física
K1 Lung rehabilitation
K1 Lung transplantation
K1 Lung volume reduction
K1 Nutrición
K1 Nutrition
K1 Oxigenoterapia
K1 Oxygen therapy
K1 Physical activity
K1 Reducción de volumen pulmonar
K1 Rehabilitación pulmonar
K1 Trasplante pulmonar
AB In addition to recommendations for pharmacological treatment stratified for risk and phenotype, the new 2021 edition of the Spanish COPD Guidelines (GesEPOC 2021) proposes a personalized approach to treatable traits, defined as a characteristic (clinical, physiological, or biological) that can be identified by diagnostic tests or biomarkers, for which a specific treatment is available. Some treatable traits, such as malnutrition, sedentarism, emphysema or respiratory failure, can be treated with non-pharmacological therapies, and this was not covered in detail in the guidelines. This section of GesEPOC 2021 includes a narrative update with recommendations on dietary treatment, physical activity, respiratory rehabilitation, oxygen therapy, non-invasive ventilation, volume reduction, and lung transplantation. A PICO question with recommendations on the use of supplemental oxygen during exercise in COPD patients without severe hypoxemia is also included.
YR 2021
FD 2021-09-17
LK http://hdl.handle.net/10668/21997
UL http://hdl.handle.net/10668/21997
LA en
LA es
DS RISalud
RD Apr 12, 2025